Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

被引:0
|
作者
Yu, MS [1 ]
Ryu, DY [1 ]
Snyderwine, EG [1 ]
机构
[1] NCI, Chem Carcinogenesis Sect, Expt Carcinogenesis Lab, Bethesda, MD 20892 USA
关键词
PhIP; mammary gland; rat;
D O I
10.1002/(SICI)1098-2744(200002)27:2<76::AID-MC3>3.0.CO;2-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhlP), a compound found in cooked meat, is a mammary gland carcinogen in female Sprague-Dawley rats. PhlP-induced rat mammary gland carcinomas were examined for mutations in several genes (exons) known to regulate cell growth and apoptosis, including p53 (4-8), p21(Waf1) (coding region), Apc(14, 15), B-catenin (3), E-cadherin (9,13,15), Bcl-x(coding region), Bar (3), IGFIIR (28), and TGFBIIR (3). DNA from 30 carcinomas was examined by single-strand conformation polymorphism analysis, but no mutations were detected in these genes or gene regions. DNA from carcinomas and matching normal tissue were further screened for allelic imbalance by using a polymerase chain reaction-based approach with primers to known microsatellite regions located throughout the rat genome. Of 53 markers examined, 12 revealed allelic imbalance. Microsatellite instability (MSI) was detected at two markers, one an chromosome 4 and one on chromosome 6. Sixty-five percent and 96% of all carcinomas examined (N=23) showed MSI at these loci on chromosomes 4 and 6, respectively, supporting the notion that MSI plays a role in PhlP-induced mammary carcinogenesis. Loss of heterozygosity (LOH), an indication of a possible tumor suppressor gene, was observed at 10 markers distributed on chromosomes 3, 10, 11, 14, and X. The frequency of LOH at these markers was 75-94%, supporting that the regions of allelic imbalance were largely similar for the PhlP-induced carcinomas examined in this study. When PhlP-induced carcinomas from rats placed on high-fat and low-fat diet were compared, no unique regions of allelic imbalance or statistical differences in the frequency of allelic imbalance were observed. Therefore, the high-fat diet, known to be a promoter of PhlP-induced rat mammary carcinogenesis, did not appear to influence allelic imbalance in the carcinomas. Interestingly, 7,12-dimethylbenz[a]anthracene-induced mammary carcinomas did not show allelic imbalance at 11 of the 12 loci that showed allelic imbalance in PhlP-induced carcinomas. These findings suggest that distinct chemical carcinogens induce different patterns of allelic imbalance during rat mammary carcinogenesis. Since several of the known genes involved in carcinogenesis did not harbor mutations in PhlP-induced carcinomas, further studies are needed to clarify the critical genes involved in PhlP-induced mammary carcinogenesis and to determine whether regions of LOH harbor potentially novel tumor suppressor genes involved in this disease. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 50 条
  • [41] Responses of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in MCF-7 cells are culture condition dependent
    Immonen, E.
    Serpi, R.
    Vahakangas, K.
    Myllynen, P.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 182 (01) : 73 - 83
  • [42] Metformin potentiates the chemotherapeutic effects of doxorubicin on 2-amino-1-methyl-6-phenylimidazo[4,5b] pyridine-induced Mammary Carcinoma in rats
    Salim, Elsayed
    El-Sisi, Alaa El-Din
    Sokar, Samia
    El-Sayad, Magda
    Moussa, Ethar
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 (04) : 700 - 713
  • [43] DNA adduct levels and absence of tumors in female rapid and slow acetylator congenic hamsters administered the rat mammary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Fretland, AJ
    Devanaboyina, US
    Nangju, NA
    Leff, MA
    Xiao, GH
    Webb, SJ
    Doll, MA
    Hein, DW
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2001, 15 (01) : 26 - 33
  • [44] Pathways of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) inhibited by basic amino acids in the glucose/ creatinine/ phenylalanine model system
    Deng, Pinghua
    Zhao, Yi
    Teng, Shuang
    Zhang, Keying
    Zhang, Yawei
    FOOD CHEMISTRY, 2025, 473
  • [45] Uptake of the colon carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different segments of the rat gastrointestinal tract: Its implication in colorectal carcinogenesis
    Nicken, Petra
    Hamscher, Gerd
    Breves, Gerhard
    Steinberg, Pablo
    TOXICOLOGY LETTERS, 2010, 196 (01) : 60 - 66
  • [46] 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation
    Andreassen, Å
    Vikse, R
    Mikalsen, A
    Adamovic, T
    Steffensen, IL
    Hjertholm, H
    Levan, G
    Alexander, J
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2006, 604 (1-2) : 60 - 70
  • [47] Short-Term Exposure to 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Induces Colonic Energy Metabolism Disorders in Rats
    Zhang, Jinhui
    Dong, Lu
    Liu, Weiye
    Sun, Yi
    Lu, Yingshuang
    Lv, Huan
    Zhang, Yan
    Wang, Shuo
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (46) : 25931 - 25943
  • [48] A mechanistic basis for the role of cycle arrest in the genetic toxicology of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)
    Creton, S
    Zhu, H
    Gooderham, NJ
    TOXICOLOGICAL SCIENCES, 2005, 84 (02) : 335 - 343
  • [49] Inhibitory effect of selected hydrocolloids on 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) formation in chemical models and beef patties
    Yang, Hongmei
    Ji, Zhiwei
    Wang, Ru
    Fan, Daming
    Zhao, Yueliang
    Wang, Mingfu
    JOURNAL OF HAZARDOUS MATERIALS, 2021, 402 (402)
  • [50] Mass Spectrometric Characterization of an Acid-Labile Adduct Formed with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Albumin in Humans
    Wang, Yi
    Villalta, Peter W.
    Peng, Lijuan
    Dingley, Karen
    Malfatti, Michael A.
    Turteltaub, K. W.
    Turesky, Robert J.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2017, 30 (02) : 705 - 714